CAS 180272-28-0
:N-ossido di solifenacina
- (1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic Acid (3R)-1-Oxido-1-azabicyclo[2.2.2]oct-3-yl Ester
- (1R,3R,4R)-3-((1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)oxy)quinuclidine 1-oxide
(R)-3-(((S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)oxy)quinuclidine 1-oxide
CAS:Formula:C23H26N2O3Purezza:98%Colore e forma:SolidPeso molecolare:378.4641Solifenacin EP Impurity I (Solifenacin N-Oxide)
CAS:Formula:C23H26N2O3Colore e forma:Off-White SolidPeso molecolare:378.47Ref: 4Z-S-1855
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaRef: ST-EA-CP-S9009
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaSolifenacin N-Oxide
CAS:Prodotto controllatoStability Very Hygroscopic
Applications A metabolite of Solifenacin (S676700) .
References Hammerlein, A., et al.: Clin. Pharmacokinet., 35, 49 (1998), Schwartz, J., et al.: Clin. Pharmacol. Ther., 55, 509 (1994),Wein, A., et al.: Expert Opin. Investig. Drugs, 10, 65 (2001),Formula:C23H26N2O3Colore e forma:NeatPeso molecolare:378.46Solifenacin N-oxide
CAS:Solifenacin N-oxide is an anti-cholinergic agent that has been shown to be effective in the treatment of overactive bladder. Solifenacin N-oxide is a prodrug that is hydrolyzed in vivo to solifenacin, its active form. The compound reversibly binds to muscarinic receptors and inhibits the release of acetylcholine. Solifenacin N-oxide has been shown to have low levels of impurities and is highly soluble in water. It was also found to be stable when stored at room temperature for two months. This drug has a high flow rate and moderate retention time, which makes it suitable for reversed-phase liquid chromatography (RPLC). RPLC is a chromatographic technique that separates compounds by size, hydrophobicity, or charge.
Formula:C23H26N2O3Purezza:Min. 95%Colore e forma:White PowderPeso molecolare:378.46 g/mol





